Related Experiment Video
Updated: Feb 7, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Protein-Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection
1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Saint Louis, MO, USA. flavio.ballante@icm.uu.se.
This study details a semi-automated method for assessing molecular docking performance using free tools. Validating docking protocols early minimizes errors in structure-based drug design and ligand-protein binding predictions.
Area of Science:
- Computational chemistry and cheminformatics
- Drug discovery and development
Background:
- Accurate prediction of ligand-protein binding poses is crucial for structure-based drug design (SBDD).
- Advancements in structural biology and computational power enable robust validation of molecular docking simulations.
- Experimental data can be systematically utilized to refine docking protocols for predicting candidate ligand binding.
Purpose of the Study:
- To describe a method for performing a comparative docking assessment.
- To enable the selection and refinement of docking protocols for predicting binding poses.
- To minimize potential failures in molecular modeling through early-stage validation.
Main Methods:
- Utilizing freely available computational tools for docking simulations.
- Implementing a semi-automated workflow for docking assessment.
- Performing comparative analysis across multiple docking software.
Main Results:
- Validation of docking performance using experimental data.
- Selection of optimal docking protocols for specific targets.
- Refinement of strategies for predicting ligand-protein interactions.
Conclusions:
- A comparative docking assessment is essential in early research stages.
- Freely available tools can be effectively used for semi-automated docking validation.
- This approach enhances the reliability of molecular modeling in drug discovery.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
05:48Cell Aggregation Assays to Evaluate the Binding of the Drosophila Notch with Trans-Ligands and its Inhibition by Cis-Ligands
Published on: January 2, 2018
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Ligand Binding and Linkage
Ligand Binding and Linkage
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...